Prior to assuming the role of Chief Medical Officer for Oncology at Natera in June 2022, Dr. Liu served as Professor of Oncology and Chair of Research in the Department of Oncology at Mayo Clinic in Rochester, MN. She also chaired the Circulating Biomarker Working Group of the Alliance for Clinical Trials in Oncology, co-chaired the Correlative Science Working Group for the Translational Breast Cancer Research Consortium, and led several multi-institutional clinical and translational research trials. Dr. Liu brings a wealth of experience in the development and validation of blood-based biomarkers to predict treatment benefit and clinical outcomes in solid tumors.